Synchrony Bio
Synchrony Bio is a venture capital firm established in 2018 and located in Saint Louis, Missouri. It focuses on early-stage investments in the biomedical, medical device, and life science sectors. The firm aims to mitigate risk while enhancing value and efficiency in the development of its portfolio companies. By concentrating on innovative ventures, Synchrony Bio seeks to contribute to advancements in healthcare and technology.
Top Regions
1 past transactions
Journeys Metabolic
Seed Round in 2019
Journeys Metabolic is a digital solution provider focused on improving metabolic care for conditions such as obesity and type 2 diabetes. The company offers a six-month program that allows patients to receive care at home, utilizing an interoperable platform that meets HITRUST standards. This physician-developed program emphasizes sustained behavior modification and employs AI-driven precision pathways, as well as computer vision technology for food education. Additionally, it incorporates proprietary biomarker assessments to evaluate fat oxidation levels. By optimizing shared savings in metabolic diseases and nutrition-related disorders, Journeys Metabolic aims to support health systems and accountable care organizations in transitioning to value-based care models, all while minimizing the burden on care teams.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.